Secondary Logo

Journal Logo

Erratum

Erratum: Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group

Author Information
doi: 10.4103/0970-2113.343593
  • Open

In the article titled “Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group”, published on pages 177-186, Issue 2, Volume 39 of Lung India[1], the third author’s name is incorrectly written as “Sahajal Dhoori.” The correct author’s name should read as “Sahajal Dhooria.”

The “How to cite this article” section should read correctly as ”Salvi SS, Ghorpade D, Dhooria S, Dhar R, Dumra H, Chhajed PN, et al. Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group. Lung India 2022;39:177-86”.

REFERENCE

1. Salvi SS, Ghorpade D, Dhoori S, Dhar R, Dumra H, Chhajed PN, et al. Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease:A review of literature and report from an expert working group Lung India 2022 39 177 86
Copyright: © 2022 Indian Chest Society